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Editorial on the Research Topic
The Bidirectional Communication Between Neurons and Immune Cells in the Development of
Psychiatric, Neurological and Immune-Mediated Disorders
The capillary distribution of neuronal terminals and immune cells throughout the body allows the
nervous and immune systems to interact and influence each other in response to different external
stimuli. Such interaction is supported by the expression of receptors for cytokines and other
immune mediators on neuronal surface, and by the expression of neurotransmitter receptors on
adaptive and innate immune cells. The constitutive release of cytokines by glial cells and T cells
residing in the meningeal space, regulate central nervous system (CNS) neuronal activity (1, 2).
Likewise, peripheral sensory neurons respond to inflammatory mediators locally released by tissue-
residing cells of the innate immune system (3). Dysfunctional communication between neurons and
immune cells is increasingly acknowledged to play a role in neurological as well as non-neurological
inflammatory and autoimmune disorders. This Research Topic includes three reviews and five
original research articles, encompassing both inflammatory and autoimmune disorders and
providing novel data and hints for future research in neuroimmunology.
The differential expression of a- and b2-adrenergic receptors on innate (macrophages) and
adaptive immune cells (T cells) has been proposed to shape the development of Rheumatoid
Arthritis (RA), an autoimmune pathology of the joints characterized by overactive sympathetic
activity (4). Bellinger et al. have shown in a rat model of RA (the adjuvant-induced arthritis) that the
combined administration of the a-adrenergic inhibitor phentolamine and the b2-adrenergic agonistorg October 2021 | Volume 12 | Article 7811511
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on joint pathology by reducing the infiltration of inflammatory
lymphocytes. Zhang and He provide an overview of the
contribution of nociceptive neurons to the pathogenesis of
psoriasis, a chronic inflammatory disease of the skin. The
authors highlighted the contribution of Transient Receptor
Potential (TRP) channels expressed on nociceptive neuronal
terminals and T-helper 17 (Th17) cells in establishing a vicious
circle that supports two classical symptoms of psoriasis: pruritus
and hyperalgesia. The article also provides evidence for the need
of further investigations on the use of anti-IL-17 antibodies and
Botox therapies in the treatment of psoriasis.
Brain antigen-specific autoimmune disorders include
Multiple Sclerosis (MS) as well as anti-AMPA and anti-NMDA
receptors encephalitis. Noteworthy, glutamate receptor
antibodies have been detected in the cerebrospinal fluid of
patients affected by neuropsychiatric disorders and pathological
disorders classically regarded as proteinopathies. These include
frontotemporal dementia (5), making hard to decipher whether
these autoantibodies have a causal role or represent an
epiphenomenon in the above-mentioned pathologies. In this
regard, Cisani et al. showed that the presence GluA2 and
GluA3 antibody complexes increase the release of glutamate
from isolated cortical synaptosomes by favoring the membrane
insertion of AMPA autoreceptors. In addition, the presence of
GluA2 or GluA3 antigen-antibody complexes in neuronal
endings facilitated the Cq1 complement-mediated glutamate
release. These findings may provide an explanation for the
symptoms related to excessive glutamatergic transmission in
pathological conditions featured by the presence of anti-GluA2
and anti-GluA3 antibodies.
The study by Alrashdi et al. addressed the role of voltage gated
sodium (Nav) channel isoform 1.6 (NaV1.6) in regulating the
immune response. The function of these channels in axonal
conductance is quite well established (6) while their role in
immune cells has been only recently explored. Mice heterozygous
for the gene encoding for NaV1.6 subjected to Experimental
Autoimmune Encephalitis (EAE) showed a reduced inflammatory
response and a decreased recruitment of myeloid cells in the optic
nerve. Interestingly, the immunomodulatory effect of these channels
was not limited to autoimmune inflammation. Indeed,
administration of lipopolysaccharide (LPS) to the same mice
showed a similar reduction in the amplitude of the inflammatory
response – thus suggesting a wider role of these channels in the
immune response of the host.
Two studies in this collection have focused on ischemic stroke.
To address the contribution of different types of immune cells to
the neurological outcome of this pathology, Liu and Sorooshyari
sought to correlate neurological deficits with the number of splenic
immune cells recruited into the brain following the Middle
Cerebral Artery Occlusion (MCAO; a murine model of stroke).
The results of these analyses suggested that microglia and splenic
T and B cells play a protective role while macrophages and
neutrophils exacerbate the motor complications observed in this
model of disease. Using the same experimental model, Zhu et al.Frontiers in Immunology | www.frontiersin.org 2proposed that administration of a selective JAK 1/2 inhibitor
Ruxolitinib - a potent tumor and immune suppressor - might be
beneficial for recovery from stroke. The study shows that targeting
the JAK2/STAT3 pathway improved neurological deficits,
neuropathological damage as infarct area, and reduced the
number of infiltrating macrophages, B and T cells, by inhibiting
the expression of pro-inflammatory cytokines and
NLRP3 inflammasome.
Finally, two reviews addressed the role of inflammation in
neurodegenerative diseases. Mancini et al. analyzed the
contribution of astrocytes and microglia to synaptic plasticity
in the striatum. This is a core area of the basal ganglia that plays a
key role in a wide range of motor, cognitive and affective
behaviors. The authors discuss how an aberrant activation of
the immune system paired with high levels of pro-inflammatory
cytokines in the basal ganglia contributes to alterations in
synaptic plasticity. Consistent with this, patients suffering from
Parkinson’s Disease (PD) have been reported to present a
heightened inflammatory response in these areas of the brain.
The minireview by Stojić-Vukanić et al. identify CD8+ T cells
as a common player in the neurocognitive impairment that
features Alzheimer’s Disease (AD) and MS. The article
provides neuropathological evidence supporting the presence
of these cells in the brain of AD and MS patients and discuss
the putative mechanisms by which CD8+ T cells cause neuronal
damage and cognitive deficits. As the authors suggested, further
investigations in this area of research might lead to the discovery
of novel dual therapies that can provide beneficial effects for both
AD and MS.
To conclude, we are aware that the articles included in this
Research Topic raise many intriguing questions more than
definite answers. We are nonetheless hopeful that our readers
will be inspired by the research presented and consider the
crosstalk between brain and immune system as a novel
exciting area of investigation.AUTHOR CONTRIBUTIONS
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